Floating Harbour Syndrome

Disease Overview

Floating Harbour Syndrome (FHS) is a rare genetic disorder characterized by distinctive physical features, developmental delays, and specific genetic mutations. First described in the early 1970s, the syndrome is named after the Floating Hospital for Children and Harbour General Hospital where initial cases were identified.

Disease Category

Rare Genetic Disorder - Chromosomal Condition - Developmental Syndrome

Synonyms

• FHS
• Floating-Harbour Syndrome
• SRCAP-Related Developmental Disorder

Signs & Symptoms

Primary Clinical Features: - Short stature - Delayed bone age - Distinctive craniofacial characteristics: - Triangular face - Deep-set eyes - Broad nasal bridge - Wide mouth - Thin upper lip - Speech and language delays - Potential intellectual developmental variations - Possible hearing impairments - Potential gastrointestinal issues - Possible cardiac and skeletal abnormalities

Causes

Genetic Etiology: - Mutations in the SRCAP gene - Typically de novo (new) mutations - Autosomal dominant inheritance pattern - Affects chromatin remodeling and gene expression - Not typically inherited from parents

Affected Populations

• Prevalence: Extremely rare
• Approximately 50 confirmed cases worldwide
• Equal gender distribution
• Global geographic representation
• No specific ethnic predisposition

Disorders with Similar Symptoms

Differential Diagnosis Considerations: - Rubinstein-Taybi syndrome - Noonan syndrome - Silver-Russell syndrome - Cornelia de Lange syndrome - 3M syndrome

Diagnosis

Diagnostic Approach: - Comprehensive clinical evaluation - Genetic testing for SRCAP mutation - Radiographic bone age assessment - Audiological examinations - Developmental screening - Molecular genetic testing

Standard Therapies

Multidisciplinary Management: - Individualized treatment plan - Growth hormone therapy - Speech and language intervention - Special education support - Potential surgical corrections - Hearing assistance technologies - Regular multidisciplinary monitoring

Clinical Trials and Studies

Current Research Focus: - Genetic mechanism understanding - Long-term developmental outcomes - Potential therapeutic interventions - Comprehensive phenotype characterization

References

• Online Mendelian Inheritance in Man (OMIM)
• Genetic and Rare Diseases Information Center
• Published case studies in medical genetics journals

Programs & Resources

Support Organizations: - National Organization for Rare Disorders (NORD) - Genetic and Rare Diseases Information Center (GARD) - International Patient Support Networks - Genetic Counseling Services

Complete Report

Floating Harbour Syndrome represents a complex genetic condition requiring specialized, personalized medical management. Ongoing research and comprehensive care are essential for optimizing patient outcomes and understanding the syndrome's intricate genetic mechanisms.